Regulus Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Joseph P Hagan | 1 | -14,580 |
Crispina Calsada | 1 | -5,468 |
Christopher Ray Aker | 1 | -5,468 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 25,516 | -25,516 |
Regulus Therapeutics Inc 内部交易
Regulus Therapeutics Inc 最新内部交易
Crispina Calsada | CFO | 2024-01-18 | 卖出 | 5,468 | 5,782 |
$1.19
|
+69.75%
|
Joseph P Hagan | CEO | 2024-01-18 | 卖出 | 14,580 | 57,112 |
$1.19
|
+69.75%
|
Christopher Ray Aker | Sr. VP & General Counsel | 2024-01-18 | 卖出 | 5,468 | 10,056 |
$1.19
|
+69.75%
|
Denis Drygin | Chief Scientific Officer | 2022-03-01 | 买入 | 767 | 100,000 |
$2.3
|
-12.17%
|
Denis Drygin | Chief Scientific Officer | 2022-02-04 | 买入 | 233 | 23,314 |
$2.3
|
-12.17%
|
Joseph P Hagan | President & CEO | 2022-01-26 | 买入 | 1,000 | 417,006 |
$2.2
|
-8.18%
|
Joseph P Hagan | President & CEO | 2021-02-16 | 卖出 | 41 | 244,628 |
$17.2
|
-88.26%
|
Joseph P Hagan | President & CEO | 2021-02-16 | 卖出 | 41 | 485,756 |
$17.2
|
-88.26%
|
Christopher Ray Aker | Sr. VP & General Counsel | 2021-02-16 | 卖出 | 8 | 42,614 |
$17.2
|
-88.26%
|
Scott D Sandell | 10% Owner | 2020-12-04 | 买入 | 43,986 | 6,451,056 |
$6.2
|
-67.42%
|